Neurocysticercosis: A Review into Treatment Options, Indications, and Their Efficacy

Overview

Journal Res Rep Trop Med

Publisher Dove Medical Press

Specialty Infectious Diseases

Date 2023 Jan 5

PMID 36601353

Authors

Pedro Tadao Hamamoto Filho

Roberto Rodriguez-Rivas

Agnes Fleury

Affiliations

Soon will be listed here.

Abstract

Neurocysticercosis, due to the localization of larvae in the Central Nervous System, is a neglected tropical disease still endemic in much of Latin America, Asia and sub-Saharan Africa. The therapeutic management of NC has gradually improved with the establishment of neuroimaging studies (CT and MRI) in endemic countries and with the demonstration of the efficacy of albendazole and praziquantel in the 1980s. But the morbidity and mortality of this preventable disease remain an unacceptable fact. In this scoping review, we will revise the different treatment options and their indications.

Citing Articles

The Pathological Fear of COVID-19 and Neuroparasitosis: A Case Report of Neurocysticercosis.

Azevedo S, Pereira S, Vilar da Mota R, Goncalves C, Costa L Cureus. 2025; 17(1):e77655.

PMID: 39968419 PMC: 11834330. DOI: 10.7759/cureus.77655.

Wild birds of Al-Jouf region may harbor zoonotic parasites.

Shaldoum F, Alsharari M, Alrashidi B Open Vet J. 2025; 14(12):3440-3448.

PMID: 39927378 PMC: 11799616. DOI: 10.5455/OVJ.2024.v14.i12.28.

From laboratory to clinical practice: an update of the immunological and molecular tools for neurocysticercosis diagnosis.

Toribio L, Bustos J, Garcia H Front Parasitol. 2025; 3():1394089.

PMID: 39817165 PMC: 11732113. DOI: 10.3389/fpara.2024.1394089.

Unveiling neurocysticercosis: A call for heightened awareness and action.

Okon I, Shafqat M, Shafqat M, Hussain J, Razouqi Y Brain Spine. 2025; 5():104174.

PMID: 39816807 PMC: 11733199. DOI: 10.1016/j.bas.2024.104174.

Treatment outcome in patients with spinal neurocysticercosis: a systematic review of published cases and case series.

Garg R, Rizvi I, Nigam H, Pandey S, Uniyal R Future Microbiol. 2024; 20(1):45-56.

PMID: 39545648 PMC: 11730807. DOI: 10.1080/17460913.2024.2428526.

References

Suri A, Goel R, Ahmad F, Vellimana A, Sharma B, Mahapatra A . Transventricular, transaqueductal scope-in-scope endoscopic excision of fourth ventricular neurocysticercosis: a series of 13 cases and a review. J Neurosurg Pediatr. 2008; 1(1):35-9. DOI: 10.3171/PED-08/01/035. View

Jung H, Hurtado M, Medina M, Sanchez M, Sotelo J . Dexamethasone increases plasma levels of albendazole. J Neurol. 1990; 237(5):279-80. DOI: 10.1007/BF00314741. View

Toledo A, Osorio R, Matus C, Martinez Lopez Y, Ramirez Cruz N, Sciutto E . Human Extraparenchymal Neurocysticercosis: The Control of Inflammation Favors the Host…but Also the Parasite. Front Immunol. 2018; 9:2652. PMC: 6250850. DOI: 10.3389/fimmu.2018.02652. View

White Jr A, Coyle C, Rajshekhar V, Singh G, Hauser W, Mohanty A . Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Am J Trop Med Hyg. 2018; 98(4):945-966. PMC: 5928844. DOI: 10.4269/ajtmh.18-88751. View

Fleury A, Carrillo-Mezo R, Flisser A, Sciutto E, Corona T . Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther. 2010; 9(1):123-33. DOI: 10.1586/eri.10.150. View

Hamamoto Filho P, Fragoso G, Sciutto E, Fleury A . Inflammation in neurocysticercosis: clinical relevance and impact on treatment decisions. Expert Rev Anti Infect Ther. 2021; 19(12):1503-1518. DOI: 10.1080/14787210.2021.1912592. View

Hamamoto Filho P, Singh G, Winkler A, Carpio A, Fleury A . Could Differences in Infection Pressure Be Involved in Cysticercosis Heterogeneity?. Trends Parasitol. 2020; 36(10):826-834. DOI: 10.1016/j.pt.2020.07.003. View

Torres-Corzo J, Tapia-Perez J, Vecchia R, Chalita-Williams J, Sanchez-Aguilar M, Sanchez-Rodriguez J . Endoscopic management of hydrocephalus due to neurocysticercosis. Clin Neurol Neurosurg. 2009; 112(1):11-6. DOI: 10.1016/j.clineuro.2009.08.022. View

Hernandez-Chea R, Morales-Ramirez P, Hernandez M, Toledo A, Hun A, Sciutto E . taeniasis/cysticercosis in Guatemala: a prevalent public health problem?. Pathog Glob Health. 2022; 117(1):5-13. PMC: 9848295. DOI: 10.1080/20477724.2022.2083757. View

10.

Kelley R, Duong D, Locke G . Characteristics of ventricular shunt malfunctions among patients with neurocysticercosis. Neurosurgery. 2002; 50(4):757-61; discussion 761-2. DOI: 10.1097/00006123-200204000-00014. View

11.

Barrie U, Badejo O, Aoun S, Adeyemo E, Moler N, Christian Z . Systematic Review and Meta-Analysis of Management Strategies and Outcomes in Adult Spinal Neurocysticercosis. World Neurosurg. 2020; 138:504-511.e8. DOI: 10.1016/j.wneu.2020.03.093. View

12.

Sotelo J, Marin C . Hydrocephalus secondary to cysticercotic arachnoiditis. A long-term follow-up review of 92 cases. J Neurosurg. 1987; 66(5):686-9. DOI: 10.3171/jns.1987.66.5.0686. View

13.

Debacq G, Moyano L, Garcia H, Boumediene F, Marin B, Ngoungou E . Systematic review and meta-analysis estimating association of cysticercosis and neurocysticercosis with epilepsy. PLoS Negl Trop Dis. 2017; 11(3):e0005153. PMC: 5340353. DOI: 10.1371/journal.pntd.0005153. View

14.

Sharawat I, Panda P, Kumar V, Sherwani P . Comparative Efficacy and Safety of Lacosamide and Oxcarbazepine for Seizure Control in Children with Newly Diagnosed Solitary Neurocysticercosis. J Trop Pediatr. 2022; 68(3). DOI: 10.1093/tropej/fmac032. View

15.

Escobedo F, Penagos P, Rodriguez J, Sotelo J . Albendazole therapy for neurocysticercosis. Arch Intern Med. 1987; 147(4):738-41. View

16.

Singh K, Saini A, Khandelwal N, Singhi P . Efficacy of Combination Therapy of Albendazole and Praziquantel vs Albendazole Monotherapy in Children With Persistent Neurocysticercosis: A Randomized Controlled Trial. J Child Neurol. 2022; 37(5):366-372. DOI: 10.1177/08830738221077762. View

17.

Woo E, Yu Y, Huang C . Cerebral infarct precipitated by praziquantel in neurocysticercosis--a cautionary note. Trop Geogr Med. 1988; 40(2):143-6. View

18.

Palomares-Alonso F, Toledo A, Palencia Hernandez G, Jung-Cook H, Fleury A . Effect of dexamethasone on albendazole cysticidal activity in experimental cysticercosis by Taenia crassiceps in BALB/c mice: In vitro and in vivo evaluation. Exp Parasitol. 2019; 208:107801. DOI: 10.1016/j.exppara.2019.107801. View

19.

Flisser A, Sarti E, Lightowlers M, Schantz P . Neurocysticercosis: regional status, epidemiology, impact and control measures in the Americas. Acta Trop. 2003; 87(1):43-51. DOI: 10.1016/s0001-706x(03)00054-8. View

20.

Minguetti G, Ferreira M . [Effect of corticoids in the acute phase of neurocysticercosis: preliminary note]. Arq Neuropsiquiatr. 1982; 40(1):77-85. DOI: 10.1590/s0004-282x1982000100008. View